Peak6 Investments LLC Repligen Corp Transaction History

Peak6 Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $14,191 - $18,225	-92 Reduced 24.02%	291 $48,000
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $62,206 - $84,474	383 New	383 $65,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $786,823 - $1.05 Million	-5,593 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $628,963 - $1.01 Million	3,902 Added 230.75%	5,593 $1.05 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $418,179 - $514,249	1,689 Added 84450.0%	1,691 $448,000
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $674,293 - $1.12 Million	-3,462 Reduced 99.94%	2 $1,000
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $468,085 - $623,520	-2,822 Reduced 44.89%	3,464 $691,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $1.13 Million - $1.42 Million	6,286 New	6,286 $1.22 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $106,765 - $148,936	-721 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $10,535 - $13,611	-86 Reduced 10.66%	721 $106,000
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $68,562 - $88,075	807 New	807 $78,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.